Open access peer-reviewed chapter

Potential Use of I. suffruticosa in Treatment of Tuberculosis with Immune System Activation

By Camila Bernardes de Andrade Carli, Marcela Bassi Quilles, Danielle Cardoso Geraldo Maia, Clarice Q. Fujimura Leite, Wagner Vilegas and Iracilda Z. Carlos

Submitted: April 4th 2011Reviewed: September 7th 2011Published: February 15th 2012

DOI: 10.5772/31846

Downloaded: 1854

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Camila Bernardes de Andrade Carli, Marcela Bassi Quilles, Danielle Cardoso Geraldo Maia, Clarice Q. Fujimura Leite, Wagner Vilegas and Iracilda Z. Carlos (February 15th 2012). Potential Use of I. suffruticosa in Treatment of Tuberculosis with Immune System Activation, Understanding Tuberculosis, Pere-Joan Cardona, IntechOpen, DOI: 10.5772/31846. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/understanding-tuberculosis-new-approaches-to-fighting-against-drug-resistance/alternative-treatments-against-mycobacterium-tuberculosis" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1854total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Multi-Drug/Extensively Drug Resistant Tuberculosis (Mdr/Xdr-Tb): Renewed Global Battle Against Tuberculosis?

By Claude Kirimuhuzya

Related Book

First chapter

Clinical Laboratory Diagnostics for Mycobacterium tuberculosis

By N. Esther Babady and Nancy L. Wengenack

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us